1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow ANCA-associated Vasculitis: new trials by email Literature Review of ANCA-associated Vasculitis trials Research Report on ANCA-associated Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abatacept in ANCA Associated Vasculitis Abatacept (Orencia) - ANCA-associated Vasculitis | Phase 2 | Terminated | Imperial College London | 7 | 2007-11-01 | 2015-05-29 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Churg-Strauss Syndrome (1) · Granulomatosis with Polyangiitis (1) · Microscopic Polyangiitis (1)
Autoimmune Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebral Small Vessel Diseases (1) · Cerebrovascular Disorders (1) · Granuloma (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Interstitial (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Nervous System Diseases (1) · Respiratory Tract Diseases (1)
Abatacept (1)
United Kingdom (1)
Alan Salama (1)